These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 14695041)

  • 41. N-acetylcysteine in the prevention of radiocontrast-induced nephropathy: clinical trials and end points.
    Hoffmann U; Banas B; Fischereder M; Krämer BK
    Kidney Blood Press Res; 2004; 27(3):161-6. PubMed ID: 15256811
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cystatin C and creatinine as markers for radiocontrast-induced nephropathy in patients treated with N-acetylcysteine.
    Merkle M; Sauter M; Argirov M; Wörnle M
    Ren Fail; 2010 Jan; 32(1):85-90. PubMed ID: 20113272
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prophylaxis of contrast material-induced nephropathy in patients in intensive care: acetylcysteine, theophylline, or both? A randomized study.
    Huber W; Eckel F; Hennig M; Rosenbrock H; Wacker A; Saur D; Sennefelder A; Hennico R; Schenk C; Meining A; Schmelz R; Fritsch R; Weiss W; Hamar P; Heemann U; Schmid RM
    Radiology; 2006 Jun; 239(3):793-804. PubMed ID: 16714461
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Contrast nephropathy after coronary angiography.
    Gami AS; Garovic VD
    Mayo Clin Proc; 2004 Feb; 79(2):211-9. PubMed ID: 14959916
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fenoldopam in the prevention of contrast media-induced acute renal failure.
    Chu VL; Cheng JW
    Ann Pharmacother; 2001 Oct; 35(10):1278-82. PubMed ID: 11675860
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevention of contrast media nephrotoxicity--the story so far.
    Morcos SK
    Clin Radiol; 2004 May; 59(5):381-9. PubMed ID: 15081843
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Radiocontrast-induced acute renal failure: allocations and outcomes.
    Mehran R; Ashby DT
    Rev Cardiovasc Med; 2001; 2 Suppl 1():S9-13. PubMed ID: 12439362
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sodium bicarbonate, N-acetylcysteine, and saline for prevention of radiocontrast-induced nephropathy. A comparison of 3 regimens for protecting contrast-induced nephropathy in patients undergoing coronary procedures. A single-center prospective controlled trial.
    Ozcan EE; Guneri S; Akdeniz B; Akyildiz IZ; Senaslan O; Baris N; Aslan O; Badak O
    Am Heart J; 2007 Sep; 154(3):539-44. PubMed ID: 17719303
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dopamine-1 receptor agonist: renal effects and its potential role in the management of radiocontrast-induced nephropathy.
    Asif A; Epstein DL; Epstein M
    J Clin Pharmacol; 2004 Dec; 44(12):1342-51. PubMed ID: 15545304
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prophylaxis of iodinated contrast media-induced nephropathy: a pharmacological point of view.
    Idé JM; Lancelot E; Pines E; Corot C
    Invest Radiol; 2004 Mar; 39(3):155-70. PubMed ID: 15076008
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acetylcysteine in the prevention of contrast-induced nephropathy after coronary angiography.
    Oldemeyer JB; Biddle WP; Wurdeman RL; Mooss AN; Cichowski E; Hilleman DE
    Am Heart J; 2003 Dec; 146(6):E23. PubMed ID: 14661012
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Can we prevent acute kidney injury?
    Venkataraman R
    Crit Care Med; 2008 Apr; 36(4 Suppl):S166-71. PubMed ID: 18382189
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intravenous N-acetylcysteine for prevention of contrast-induced nephropathy: a meta-analysis of randomized, controlled trials.
    Sun Z; Fu Q; Cao L; Jin W; Cheng L; Li Z
    PLoS One; 2013; 8(1):e55124. PubMed ID: 23383076
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rationale, design, and baseline characteristics of the Acetylcystein for Contrast-Induced nephropaThy (ACT) Trial: a pragmatic randomized controlled trial to evaluate the efficacy of acetylcysteine for the prevention of contrast-induced nephropathy.
    ACT Trial Investigators
    Trials; 2009 Jun; 10():38. PubMed ID: 19497091
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Use of fenoldopam for prevention of radiocontrast nephropathy in the cardiac catheterization laboratory: a case series.
    Madyoon H; Croushore L
    J Interv Cardiol; 2001 Apr; 14(2):179-85. PubMed ID: 12053301
    [TBL] [Abstract][Full Text] [Related]  

  • 56. N-acetylcysteine for the prevention of contrast-induced nephropathy in patients with pre-existing renal insufficiency or diabetes: a systematic review and meta-analysis.
    Kang X; Hu DY; Li CB; Ai ZS; Peng A
    Ren Fail; 2015 Nov; 37(10):297-303. PubMed ID: 26458505
    [TBL] [Abstract][Full Text] [Related]  

  • 57. N-Acetylcysteine in nephrology; contrast nephropathy and beyond.
    Tepel M; Zidek W
    Curr Opin Nephrol Hypertens; 2004 Nov; 13(6):649-54. PubMed ID: 15483456
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Is acetylcysteine effective in preventing contrast-related nephropathy? A meta-analysis.
    Nallamothu BK; Shojania KG; Saint S; Hofer TP; Humes HD; Moscucci M; Bates ER
    Am J Med; 2004 Dec; 117(12):938-47. PubMed ID: 15629733
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevention of contrast-induced nephropathy by N-acetylcysteine in critically ill patients: different definitions, different results.
    Chousterman BG; Bouadma L; Moutereau S; Loric S; Alvarez-Gonzalez A; Mekontso-Dessap A; Laissy JP; Rahmouni A; Katsahian S; Brochard L; Schortgen F
    J Crit Care; 2013 Oct; 28(5):701-9. PubMed ID: 23683568
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sodium bicarbonate therapy for prevention of contrast-induced nephropathy: a systematic review and meta-analysis.
    Navaneethan SD; Singh S; Appasamy S; Wing RE; Sehgal AR
    Am J Kidney Dis; 2009 Apr; 53(4):617-27. PubMed ID: 19027212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.